Atara Biotherapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ATRA Nasdaq 2836 www.atarabio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Atara Biotherapeutics, Inc.

ATRA Stock Down After FDA Issues CRL for Rare Blood Cancer Candidate - Jan 17th, 2025 2:24 pm
Atara Biotherapeutics Shares Plunge 38% Following FDA Response to EBVALLO Application - Jan 16th, 2025 5:28 pm
Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLOTM (tabelecleucel) - Jan 16th, 2025 1:30 pm
Has Incyte (INCY) Outpaced Other Medical Stocks This Year? - Jan 13th, 2025 2:40 pm
Here's Why You Should Consider Buying Atara Biotherapeutics Stock - Jan 8th, 2025 3:44 pm
Atara Biotherapeutics, Inc.'s (NASDAQ:ATRA) high institutional ownership speaks for itself as stock continues to impress, up 27% over last week - Jan 8th, 2025 10:17 am
Atara Biotherapeutics (ATRA) Upgraded to Buy: Here's Why - Jan 2nd, 2025 5:00 pm
Presenting on the Emerging Growth Conference 77 Day 2 on December 5th Register Now - Dec 4th, 2024 12:00 pm
Atara Biotherapeutics to Participate at the 7th Annual Evercore ISI HealthCONx Conference - Nov 27th, 2024 9:01 pm
Atara Biotherapeutics Third Quarter 2024 Earnings: Beats Expectations - Nov 15th, 2024 12:03 pm
Atara Biotherapeutics to Participate at the Stifel 2024 Healthcare Conference - Nov 13th, 2024 9:01 pm
Atara Biotherapeutics (ATRA) Reports Q3 Loss, Tops Revenue Estimates - Nov 12th, 2024 10:15 pm
Atara Biotherapeutics: Q3 Earnings Snapshot - Nov 12th, 2024 9:13 pm
Atara Biotherapeutics Announces Third Quarter 2024 Financial Results and Operational Progress - Nov 12th, 2024 9:01 pm
Atara Biotherapeutics to Announce Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - Nov 5th, 2024 9:01 pm
Atara Biotherapeutics (ATRA) Upgraded to Buy: Here's What You Should Know - Oct 15th, 2024 4:00 pm
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Oct 4th, 2024 8:01 pm
After scoring a first for an off-the-shelf T cell therapy, can Atara maintain momentum? - Sep 30th, 2024 7:16 am
Redmile Group, LLC Expands Stake in Atara Biotherapeutics Inc - Sep 13th, 2024 11:02 pm
Atara Biotherapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - Sep 4th, 2024 8:01 pm